Ubs Asset Management Americas Inc Danaher Corp Transaction History

Ubs Asset Management Americas Inc

$345 Billion
Q2 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Danaher Corp stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 4,949,735 shares of DHR stock, worth $1.36 Billion. This represents 0.36% of its overall portfolio holdings.

Number of Shares

4,949,735

Previous 3,805,105 30.08%

Holding current value

$1.36 Billion

Previous $950 Million 30.15%

% of portfolio

0.36%

Previous 0.34%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$235.51 - $267.98 $270 Million - $307 Million	1,144,630 Added 30.08%	4,949,735 $1.24 Billion
Q1 2024 May 15, 2024	SELL	$224.58 - $256.19 $8.63 Million - $9.85 Million	-38,447 Reduced 1.0%	3,805,105 $950 Million
Q4 2023 Feb 14, 2024	BUY	$185.1 - $233.13 $20.9 Million - $26.3 Million	112,803 Added 3.02%	3,843,552 $889 Million
Q3 2023 Nov 13, 2023	BUY	$233.08 - $265.59 $225 Million - $257 Million	966,797 Added 34.98%	3,730,749 $926 Million
Q1 2023 May 15, 2023	SELL	$239.75 - $277.0 $52.8 Million - $61 Million	-220,347 Reduced 7.38%	2,763,952 $697 Million
Q4 2022 Feb 14, 2023	BUY	$241.42 - $282.29 $9.35 Million - $10.9 Million	38,749 Added 1.32%	2,984,299 $792 Million
Q3 2022 Nov 14, 2022	SELL	$247.06 - $1507.4 $90.5 Million - $552 Million	-366,305 Reduced 11.06%	2,945,550 $761 Million
Q2 2022 Aug 12, 2022	BUY	$237.11 - $299.66 $33.5 Million - $42.3 Million	141,129 Added 4.45%	3,311,855 $840 Million
Q1 2022 May 16, 2022	SELL	$257.27 - $315.76 $164 Million - $201 Million	-635,963 Reduced 16.71%	3,170,726 $930 Million
Q4 2021 Feb 14, 2022	SELL	$292.08 - $329.01 $326 Million - $367 Million	-1,116,914 Reduced 22.68%	3,806,689 $1.25 Billion
Q3 2021 Nov 15, 2021	BUY	$272.21 - $332.43 $322 Million - $393 Million	1,181,343 Added 31.57%	4,923,603 $1.5 Billion
Q2 2021 Aug 16, 2021	BUY	$225.08 - $271.69 $124 Million - $150 Million	552,512 Added 17.32%	3,742,260 $1 Billion
Q1 2021 May 14, 2021	BUY	$212.38 - $245.9 $18.7 Million - $21.7 Million	88,077 Added 2.84%	3,189,748 $718 Million
Q4 2020 Mar 01, 2021	SELL	$212.5 - $245.46 $251 Million - $290 Million	-1,181,489 Reduced 27.58%	3,101,671 $689 Million
Q3 2020 Nov 13, 2020	SELL	$177.16 - $215.33 $14.9 Million - $18.1 Million	-83,874 Reduced 1.92%	4,283,160 $922 Million
Q2 2020 Aug 14, 2020	SELL	$128.7 - $176.83 $81.1 Million - $111 Million	-630,281 Reduced 12.61%	4,367,034 $772 Million
Q1 2020 May 15, 2020	BUY	$121.39 - $169.05 $9.14 Million - $12.7 Million	75,312 Added 1.53%	4,997,315 $692 Million
Q4 2019 Feb 14, 2020	SELL	$133.47 - $153.48 $84.2 Million - $96.9 Million	-631,086 Reduced 11.36%	4,922,003 $755 Million
Q3 2019 Nov 14, 2019	BUY	$135.4 - $146.47 $174 Million - $189 Million	1,288,182 Added 30.2%	5,553,089 $802 Million
Q2 2019 Aug 15, 2019	SELL	$124.88 - $143.73 $55.3 Million - $63.7 Million	-442,945 Reduced 9.41%	4,264,907 $0
Q1 2019 May 14, 2019	SELL	$97.62 - $132.29 $47.7 Million - $64.6 Million	-488,445 Reduced 9.4%	4,707,852 $0
Q4 2018 Feb 13, 2019	BUY	$94.85 - $109.54 $121 Million - $139 Million	1,271,508 Added 32.4%	5,196,297 $536 Million
Q3 2018 Nov 14, 2018	BUY	$98.13 - $108.9 $101 Million - $112 Million	1,028,706 Added 35.52%	3,924,789 $0
Q2 2018 Aug 14, 2018	SELL	$96.1 - $103.24 $6.44 Million - $6.92 Million	-66,989 Reduced 2.26%	2,896,083 $0
Q1 2018 May 14, 2018	BUY	$92.16 - $103.8 $15.9 Million - $17.9 Million	172,204 Added 6.17%	2,963,072 $0
Q4 2017 Feb 09, 2018	SELL	$85.26 - $94.62 $11.4 Million - $12.7 Million	-133,958 Reduced 4.58%	2,790,868 $0
Q3 2017 Nov 13, 2017	BUY	$79.29 - $88.45 $232 Million - $259 Million	2,924,826	2,924,826 $0

Others Institutions Holding DHR

# of Institutions

2,389

Shares Held

563M

Call Options Held

3.94M

Put Options Held

4.1M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $201B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Danaher Corp Transaction History